Denosumab


( Last Updated : October 26, 2015)
Generic Name:
Denosumab
Project Status:
Complete
Therapeutic Area:
Osteoporosis
Manufacturer:
Amgen Canada Inc.
Call for patient/clinician input open:
Brand Name:
Prolia
Project Line:
Reimbursement Review
Project Number:
SF0453-000
Call for patient/clinician input closed:

Details


Submission Type:
Request For Advice
Indications:
Osteoporosis, postmenopausal women
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: